Skip to main content
TipRanks
Go Ultimate75% OFF

AIM Vaccine Co., Ltd. Class H (6660) Stock Price & Analysis

2 Followers

6660 Stock Chart & Stats

HK$1.50HK$0.00(0.00%)
At close: 4:00 PM GMT+8
HK$1.5HK$1.75Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 10
Day’s Range
HKD 1.50 - HKD 1.50
52-Week Range
HKD 1.20 - HKD 3.78
Previous Close
HKD 1.50
Volume
N/A
Average Volume (3M)
117.81K
Market Cap
HKD 1.83B
Enterprise Value
HKD 4.06B
Total Cash (Recent Filing)
HKD 193.15M
Total Debt (Recent Filing)
HKD 1.77B
Price to Earnings (P/E)
―
Beta
1.22
Next Earnings
Apr 01, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Integrated Vaccine Business

The company spans vaccine research, development, manufacturing, and commercialization, giving it control across the product lifecycle. This integrated model can support better coordination between development and distribution, while an established focus on the Chinese market provides a defined platform for future product adoption.

Strong Gross Margins

Gross margins of roughly 62%–74% indicate that the underlying vaccine products retain meaningful economic value before operating expenses. If maintained, this margin structure can provide a foundation for recovery as revenue scales, although the company still needs to address the high costs that currently prevent profitability.

Positive Operating Cash Flow

Positive operating cash flow in the latest two periods suggests the core business is generating cash from operations despite reported losses. This is a constructive foundation for financial durability because it may help fund routine activity internally, even though investment spending continues to keep free cash flow negative.

Bears Say

Revenue Decline

The return to revenue contraction after only modest prior growth points to weak near-term commercial momentum. Persistent top-line pressure can reduce operating leverage, limit the company’s ability to absorb fixed costs, and make it harder for strong gross margins to translate into sustainable earnings over the next several quarters.

Persistent Losses

Large net losses, negative operating profitability, and a -23.84% return on equity show that the business is not currently converting its platform into shareholder returns. Continued losses could consume capital, constrain reinvestment, and increase the risk of further value dilution if profitability does not recover.

Negative Free Cash Flow

Ongoing negative free cash flow means investment spending continues to exceed internally generated cash, despite positive operating cash flow. If this pattern persists, the company may need additional funding to support development and operations, reducing financial flexibility and potentially increasing reliance on external capital.

AIM Vaccine Co., Ltd. Class H News

6660 FAQ

What was AIM Vaccine Co., Ltd. Class H’s price range in the past 12 months?
AIM Vaccine Co., Ltd. Class H lowest stock price was HK$1.20 and its highest was HK$3.78 in the past 12 months.
What is AIM Vaccine Co., Ltd. Class H’s market cap?
AIM Vaccine Co., Ltd. Class H’s market cap is HK$1.83B.
When is AIM Vaccine Co., Ltd. Class H’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were AIM Vaccine Co., Ltd. Class H’s earnings last quarter?
AIM Vaccine Co., Ltd. Class H released its earnings results on Aug 23, 2026. The company reported -HK$0.117 earnings per share for the quarter.
Is AIM Vaccine Co., Ltd. Class H overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does AIM Vaccine Co., Ltd. Class H pay dividends?
AIM Vaccine Co., Ltd. Class H does not currently pay dividends.
What is AIM Vaccine Co., Ltd. Class H’s EPS estimate?
AIM Vaccine Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AIM Vaccine Co., Ltd. Class H have?
AIM Vaccine Co., Ltd. Class H has 507,673,700 shares outstanding.
What happened to AIM Vaccine Co., Ltd. Class H’s price movement after its last earnings report?
AIM Vaccine Co., Ltd. Class H reported an EPS of -HK$0.117 in its last earnings report. Following the earnings report the stock price went down -0.667%.
Which hedge fund is a major shareholder of AIM Vaccine Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:6660
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology